Cav-1 expression is frequently down-regulated in many human cancers mainly due to promoter hypermethylation whereas its elevation correlates with enhanced progression, multidrug resistance, and metastatic potentials of certain tumors [3–6]. Here, CAV1 is linked to cancer.